51
Lipid Coated SPIO; Introducing a Novel Tracer for MR Imaging of Macrophage Infiltration in Vulnerable Atherosclerotic Plaque Center for Vulnerable Plaque Research University of Texas-Houston and Texas Heart Institute, Houston, Texas

Acc presentation lipid coated(2)

Embed Size (px)

Citation preview

Page 1: Acc presentation lipid coated(2)

Lipid Coated SPIO;Introducing a Novel Tracer for MR

Imaging of Macrophage Infiltration in Vulnerable Atherosclerotic Plaque

Center for Vulnerable Plaque Research

University of Texas-Houston andTexas Heart Institute, Houston, Texas

Page 2: Acc presentation lipid coated(2)

Rupture Prone Inflamed Plaque

Page 3: Acc presentation lipid coated(2)

SPIOSPIOSuper Paramagnetic Super Paramagnetic

Iron OxideIron Oxide

lBlood pool magnetic resonance (MR) imaging contrast media with a central core of iron oxide generally coated by a polysaccharide layer

lShortening MR relaxation time

lEngulfed by and accumulated inside cells with phagocytic activity

Page 4: Acc presentation lipid coated(2)

FL-labeled SPIO Incubated Macrophages 24hr

Page 5: Acc presentation lipid coated(2)

Double DAPI Staining with Fluorescence-labeled SPIO Macrophages after 24hr Incubation

Page 6: Acc presentation lipid coated(2)

Hypercholesterolemic Rabbit, Aorta, 10 days after SPIO injection

Perls’ Staining H&E Staining X10 X10

Page 7: Acc presentation lipid coated(2)

Hypercholesterolemic Rabbit, Aorta, 4 days after SPIO injection

Perls’ Staining H&E Staining X40 X40

Page 8: Acc presentation lipid coated(2)

Histopathologic studies of Thoracic aorta in Watanabe Hereditary Hypercholesterolemic rabbit after SPIO

injection

H&E staining

Macrophage staining Iron staining

Page 9: Acc presentation lipid coated(2)

MR Angiography 3D with Gadolinium-DTPA in Watanabe Rabbit

3D-TOFTR=59msTE=7.0msFlip=30

3D-TOF

TR=59ms

TE=7.0ms

Flip=30

After SPIO injectionBefore SPIO injection

Baseline Day 5

Page 10: Acc presentation lipid coated(2)

Ex-vivo MR Study of Thoracic Aorta in SPIO-injected Atherosclerotic and Normal Rabbits after Compared to Non-

injected Controls.

Watanabe rabbitpost-SPIO

Watanabe rabbitwithout SPIO

NZW rabbit

Page 11: Acc presentation lipid coated(2)

Control

SPIO Injected

Schmitz et al J. Inv. Radiol. 2000

Page 12: Acc presentation lipid coated(2)
Page 13: Acc presentation lipid coated(2)

Goals:

• Increase contrast enhancement by increasing macrophage uptake of SPIO

• Decrease SPIO induced macrophage activity and free radical formation

Page 14: Acc presentation lipid coated(2)

SPIO Characteristics

• SIZE• Surface Charge• Coating Composition

Page 15: Acc presentation lipid coated(2)

Particle Core Size Particle Size Blood

(nm) (nm) Half-life

Combidex 5-6 20-30 8h

Feridex 4-6 35-50 2.4±0.2h

DDM 43/34/102 6.4 20-30 6h

Clariscan

MION 4-6 17 varies

Feruglose

--- --- --- ---

Examples of commercially available SPIOs

Page 16: Acc presentation lipid coated(2)

SPIO Coating√ Macrophage Uptake

Macrophage Activity

• Dextran Coated• Condrotin Sulfate Coated• Liposomal Coated• Combined lipid and protein Coated

Page 17: Acc presentation lipid coated(2)

Home Made SPIO

• 1. SPIO coated with chondroitin sulfate• 2 SPIO coated with standard dextran

(6K)• 3 SPIO coated with Amino-silane• 4 SPIO coated with lipids• 5 Lipid encapsulated SPIO coated with

amino-silane

Page 18: Acc presentation lipid coated(2)

Uptake of SPIO by murine peritoneal macrophages and monocytes

• Normal mice were treated with mineral oil by ip injection.

• 24 hours later, equal amount of various SPIO were injected intraperitoneally.

• 24 hours later, peritoneal macrophages and monocytes were isolated.

• Uptakes of various SPIO were examined by light microscopy.

Page 19: Acc presentation lipid coated(2)

Uptake by Mouse Macrophages

SPIO coated with standard Dextran (6 K)

Page 20: Acc presentation lipid coated(2)
Page 21: Acc presentation lipid coated(2)
Page 22: Acc presentation lipid coated(2)
Page 23: Acc presentation lipid coated(2)
Page 24: Acc presentation lipid coated(2)

Uptake by Mouse Macrophages

SPIO coated with amino-silane

Page 25: Acc presentation lipid coated(2)
Page 26: Acc presentation lipid coated(2)
Page 27: Acc presentation lipid coated(2)
Page 28: Acc presentation lipid coated(2)

Uptake by Mouse Macrophages

SPIO coated with lipids

Page 29: Acc presentation lipid coated(2)
Page 30: Acc presentation lipid coated(2)
Page 31: Acc presentation lipid coated(2)
Page 32: Acc presentation lipid coated(2)

Uptake by Mouse macrophages

SPIO coated with CS

Page 33: Acc presentation lipid coated(2)
Page 34: Acc presentation lipid coated(2)
Page 35: Acc presentation lipid coated(2)
Page 36: Acc presentation lipid coated(2)

Uptake by Mouse Macrophages

Lipid encapsulated SPIO coated with amino-silane

Page 37: Acc presentation lipid coated(2)
Page 38: Acc presentation lipid coated(2)
Page 39: Acc presentation lipid coated(2)
Page 40: Acc presentation lipid coated(2)

SPIO Coating Macrophage Uptake

√ Macrophage Activity

• Dextran Coated• Condrotin Sulfate Coated• Liposomal Coated• Combined lipid and protein Coated

Page 41: Acc presentation lipid coated(2)

Principle

• Any event of phagocytosis is immediately followed by a transient release of super oxide due to the assembly of the NADPH oxidase against the plasma membrane. Subsequently the oxidase translocates onto the phagosomes containing the SPIO to produce intracellular ROS.

• Thus an early extra cellular secretion of super oxide is detectable (using luminol) soon after phagocytosis and a later event of intracellular secretion is measurable using DCFDA dye .

Page 42: Acc presentation lipid coated(2)

Detection of macrophage viability after ROS production

• Viable macrophages convert the Alamar blue dye into an orange colored product measurable in a Elisa reader. AB is a widely used method to measure viability.

• The hypothesis we are testing is that cells that make ROS may die and lose viability. Thus if SPIO stimulates ROS within the cells does it lead to cell death over time ??

Page 43: Acc presentation lipid coated(2)

Method

 The suspension of SPIO (1.25-10 micromol/mL) was added to macrophages (1x104/well in 96 well plates). Cells were incubated for 1 h or 24 h and washed to remove extracellular SPIO. For each dose three wells were tested.

 AB dye at 20% volume was added to the macrophage plate and incubated for 4 h at 37oC and 5% Co2. They were read for viability using an Elisa at 570 nm

Page 44: Acc presentation lipid coated(2)

Results

• Both SPIO treated as well as untreated macrophages had same level of viability as shown in the following slide at 24 h post SPIO treatment.

Page 45: Acc presentation lipid coated(2)

Viability Values with Alamar Blue

0.5850.59

0.5950.6

0.6050.61

0.6150.62

0.6250.63

1.25 /mL 2.5 /ml 5 /mL 10 /mL Untreated

Sample1Sample2Sample3

Page 46: Acc presentation lipid coated(2)

Studies of Macrophage Receptor Pathways for SPIO:

1) Uptake √2) Activity

Page 47: Acc presentation lipid coated(2)

Inhibition of the Uptake of SPIO Using Mannan andDextran ( Competitive Inhibitor of Mannose Receptor )

SPIO SPIO+Dex SPIO+Man Control0

25

50

75

SPIO aloneSPIO+DextranSPIO+Mannan

Control

*

*

Combination

AFU

/104

Mac

roph

ages

( SP

IO U

ptak

e)

Page 48: Acc presentation lipid coated(2)

Studies of Macrophage Receptor Pathways for SPIO:

1) Uptake 2) Activity √

Page 49: Acc presentation lipid coated(2)

Induction of Nitric Oxide by SPIO and LPIO-particles inMacrophages -24 h (Experiment-1)

DEX-1 DEX-2 LIP-1 LIP-2 LIP-3 LIP-4 Feridex Control0.0

0.1

0.2

0.3

DEX-1DEX-2

LIP-1LIP-2LIP-3LIP-4

FeridexControl

SPIOLPIO

SPIO or LPIO particles

OD

550

(Nitr

ite le

vel)

Page 50: Acc presentation lipid coated(2)

Conclusion

• Macrophage uptake of SPIO varies by SPIO size, surface charge and coating material.

• SPIO uptake does not affect macrophage viability.

• SPIO induces transient increased macrophage activity.

• Liposomal coated SPIOs combined with certain aminoglycans offer highest macrophage uptake with lowest oxidative stress.

Page 51: Acc presentation lipid coated(2)

Center for Vulnerable Plaque Research Houston, Texas